#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Malignant neoplasm of choroid Fallopian tube cancer Castleman's disease Neurodegenerative disorder Ischaemic stroke Angiosarcoma non-metastatic Osteogenesis imperfecta Glomerulonephritis rapidly progressive Mucopolysaccharidosis II Univentricular heart Hepatic angiosarcoma Lymphangioma Deafness neurosensory Pneumonia Carcinoid syndrome More trials…

    Learn about Rare Diseases

    Combined immunodeficiency – Trials in Disease Hereditary optic atrophy – Trials in Disease Ornithine transcarbamoylase deficiency – Diagnostics Krabbe’s disease – Life with Disease Hereditary hypophosphataemic rickets – Trials in Disease Hyperoxaluria – Life with Disease Epidermolysis bullosa – Diagnostics Congenital nephrogenic diabetes insipidus – Trials in Disease Glomerulonephritis rapidly progressive – Treatment Pemphigoid – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Abc-23B-116 [18F]DED Fosinopril Sodium Bt8009 Omp66 Encaleret Sulfate GSKVX000000034794 Nemtabrutinib Melphalan Hydrochloride Tedizolid Phosphate C1 Esterase Inhibitor (Human) Emapalumab Batoclimab Tolvaptan Efgartigimod Alfa Benzathine Benzylpenicillin CARBACHOL Escitalopram Oxalate Mk-2060 Botulinum Toxin Type A More therapies…

    Learn about Your Condition

    Anogenital dysplasia Hypochromic anaemia Apathy Endometrial cancer stage III Skin wrinkling Aicardi-Goutieres syndrome Immune-mediated renal disorder Arthritis infective Hepatic angiosarcoma Labour pain Carotid arteriosclerosis Lumbosacral radiculopathy Endolymphatic hydrops Chorioretinitis Hypervolaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Of Debrecen

University Of Debrecen

Mgkxlf Zkmvpbyo Kxbat 2zn Dceqqqmyo 4bera Hfotvgf

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effects of Zalunfiban for Patients with ST-Elevation Myocardial Infarction (Heart Attack)

    Not recruiting

    3 1
    Investigated Diseases:
    • Acute cardiac event
    • Myocardial ischaemia
    • Acute myocardial infarction
    Investigated Drugs:
    • Zalunfiban
    Czechia France Hungary The Netherlands Romania

  • Study of Pembrolizumab, Cisplatin, and Gemcitabine for Patients with Muscle-Invasive Bladder Cancer Eligible for Cisplatin Treatment

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Bladder cancer stage II
    • Bladder cancer stage III
    • Bladder cancer
    Investigated Drugs:
    • Cisplatin
    • Gemcitabine
    • Pembrolizumab
    Belgium Denmark France Germany Hungary Ireland +4

  • Study on Long-Term Safety and Efficacy of Amlitelimab for Patients with Moderate to Severe Atopic Dermatitis from Previous Trials

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Amlitelimab
    Bulgaria Czechia Denmark France Germany Greece +7

  • Study of Venetoclax and Azacitidine for Patients with Acute Myeloid Leukemia After Stem Cell Transplant

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Azacitidine
    • Venetoclax
    Czechia France Germany Greece Hungary Italy +1

  • Study on Andexanet Alfa for Patients on Factor Xa Inhibitors (Apixaban, Rivaroxaban, Edoxaban) Needing Urgent Surgery to Reduce Bleeding Risk

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Aminocaproic Acid
    • Blood And Related Products
    • Etamsylate
    Austria Belgium Bulgaria Czechia Denmark Estonia +13

  • Study of Tafasitamab, Lenalidomide, and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Tafasitamab
    • Lenalidomide
    • Rituximab
    Austria Belgium Czechia Denmark Finland France +10

  • Study on the Effects of AZD0780 on Cholesterol Levels in Adults Aged 18-75 with Dyslipidemia

    Not recruiting

    2 1
    Investigated Diseases:
    • Dyslipidaemia
    Investigated Drugs:
    • 1-[6-[[(1S,3S)-3-[[5-(Difluoromethoxy)Pyrimidin-2-Yl]Amino]Cyclopentyl]Amino]Pyridin-3-Yl]Pyridin-2-One
    Czechia Denmark Hungary Slovakia Spain

  • Study on Guselkumab and Etanercept for Treating Chronic Plaque Psoriasis in Children Aged 6 to 17 Years

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Psoriasis
    Investigated Drugs:
    • Etanercept
    • Guselkumab
    Belgium Germany Hungary Italy Poland

  • Study on Baricitinib for Hospitalized Patients with Severe or Critical COVID-19

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Lung disorder
    Investigated Drugs:
    • Baricitinib
    Austria Belgium Czechia France Germany Greece +8

  • Study of CGT9486 and Sunitinib for Patients with Advanced Gastrointestinal Stromal Tumors

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Gastrointestinal stromal tumour
    Investigated Drugs:
    • 3,4-Dimethyl-N-(2-Phenyl-1H-Pyrrolo[2,3-B]Pyridin-5-Yl)-1H-Pyrazole-5-Carboxamide
    • Sunitinib
    Czechia Denmark France Germany Hungary Italy +5
Previous Page
1 … 44 45 46 47 48 … 52
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!